Nanalysis Scientific Corp. announced that, effective January 1, 2022, Dr. René Lenggenhager, is joining its Board of Directors. Dr. Lenggenhager is an experienced public company executive and board member with a successful career in leading global technology companies. Dr. Lenggenhager brings to Nanalysis a diverse set of experiences and capabilities over a 37 year career in advanced industrial technology. He has a background of continuously innovating technology components and systems, with a focus on high-precision measuring, testing and automation equipment. His experience includes over 20 years of management and development, with full P&L responsibility, of globally active, publicly listed, innovative technology companies: Comet Group (COTN), Bruker BioSpin (BRKR), Mettler-Toledo (MTD) and Siemens Building Technologies. During his career he defined and implemented new product strategies for low- to high-field Nuclear Magnetic Resonance (NMR) products, and consolidated all service activities into one service division.